{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:37:48Z","timestamp":1768631868120,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jpag.2013.05.007","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T01:48:25Z","timestamp":1378345705000},"page":"290-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Isotretinoin: Update on Controversial Issues"],"prefix":"10.1016","volume":"26","author":[{"given":"Noel","family":"Prevost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Joseph C.","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2013.05.007_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jpag.2007.07.004","article-title":"Adolescent female acne: etiology and management","volume":"21","author":"Olutunmbi","year":"2008","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2013.05.007_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clindermatol.2009.03.005","article-title":"The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies","volume":"28","author":"Rigopoulos","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2010.06.040","article-title":"Effective monitoring of isotretinoin safety in a pediatric dermatology population: a novel \u201cpatient symptom survey\u201d approach","volume":"65","author":"Hodgkiss-Harlow","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.clindermatol.2011.08.026","article-title":"Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero","volume":"29","author":"Lowenstein","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ibd.22990","article-title":"Drug-induced inflammatory bowel disease and IBD-like conditions","volume":"19","author":"Dubeau","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jpag.2013.05.007_bib6","series-title":"Andrews' Diseases of the Skin: Clinical Dermatology","author":"James","year":"2011"},{"key":"10.1016\/j.jpag.2013.05.007_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4088\/JCP.10r05993","article-title":"Retinoic acid and affective disorders: the evidence for an association","volume":"73","author":"Bremner","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpag.2013.05.007_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-0960.2010.00657.x","article-title":"Adverse effects of isotretinoin: A restrospective review of 1743 patients started on isotretinoin","volume":"51","author":"Rademaker","year":"2010","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2009.09.005","article-title":"Psychiatric reactions to isotretinoin in patients with bipolar disorder","volume":"122","author":"Schaffer","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jpag.2013.05.007_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to severe acne; a cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1468-3083.2011.04089.x","article-title":"Isotretinoin has no negative effect on attention, executive function and mood","volume":"26","author":"Ergun","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jpag.2013.05.007_bib12","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1365-2133.2010.09836.x","article-title":"Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010","volume":"162","author":"Goodfield","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib13","first-page":"985","article-title":"Beneficial effect of moisturizing cream as adjunctive treatment to oral isotretinoin of topical tretinoin in the management of acne","volume":"5","author":"Laquieze","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archdermatol.2012.352","article-title":"Ocular adverse effects of systemic treatment with isotretinoin","volume":"148","author":"Neudorfer","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib15","first-page":"52","article-title":"Isotretinoin-induced inflammatory bowel disease","volume":"64","author":"Passier","year":"2006","journal-title":"Neth J Med"},{"key":"10.1016\/j.jpag.2013.05.007_bib16","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1572-0241.2006.00632.x","article-title":"Possible association between isotretinoin and inflammatory bowel disase","volume":"101","author":"Reddy","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jpag.2013.05.007_bib17","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/ajg.2010.124","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a case-control study","volume":"105","author":"Crockett","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jpag.2013.05.007_bib18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archdermatol.2011.116","article-title":"Isotretinoin therapy and inflammatory bowel disease","volume":"147","author":"Popescu","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib19","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/ajg.2010.303","article-title":"Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease","volume":"105","author":"Margolis","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jpag.2013.05.007_bib20","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaad.2011.04.016","article-title":"Acne treatment and inflammatory bowel disease: what is the evidence?","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/jid.2012.387","article-title":"Canadian Drug Safety and Effectiveness Research Network: Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study","volume":"133","author":"Alhusayen","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1067\/mjd.2003.540","article-title":"Connections between psoriasis and Crohn's disease","volume":"48","author":"Najarian","year":"2003","journal-title":"J\u00a0Am Acad Dermatal"},{"key":"10.1016\/j.jpag.2013.05.007_bib23","first-page":"505","article-title":"Inflammatory bowel disease: adverse effect of isotretinoin","volume":"11","author":"Papageorgiou","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jpag.2013.05.007_bib24","first-page":"92","article-title":"An update on the presence of psychiatric comorbidities in acne patients, Part 2: Depression, anxiety, and suicide","volume":"88","author":"Saitta","year":"2011","journal-title":"Cutis"},{"key":"10.1016\/j.jpag.2013.05.007_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/09546630903164909","article-title":"Evaluation of depressive symptoms in acne patients treated with isotretinoin","volume":"20","author":"Bozda\u011f","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jpag.2013.05.007_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.sder.2005.04.003","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"24","author":"Marqueling","year":"2005","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jpag.2013.05.007_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-859X-8-2","article-title":"Isotretinoin and psychopathology: a review","volume":"8","author":"Kontaxakis","year":"2009","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.jpag.2013.05.007_bib28","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.npp.1300998","article-title":"Chronic administration of\u00a013-cis-retinoic acid increases depression-related behavior in mice","volume":"31","author":"O'Reilly","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpag.2013.05.007_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00045391-200303000-00012","article-title":"Overview of existing research and information linking isotretinoin (accutane), depression, psychosis, and suicide","volume":"10","author":"O'Donnell","year":"2003","journal-title":"Am J Ther"},{"key":"10.1016\/j.jpag.2013.05.007_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM199507133330206","article-title":"A pregnancy-prevention program in women of childbearing age receiving isotretinoin","volume":"333","author":"Mitchell","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2013.05.007_bib31","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-4632.2011.04875.x","article-title":"Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential","volume":"50","author":"AlGhamdi","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaad.2011.04.006","article-title":"Isotretinoin and IPledge: a view of results","volume":"65","author":"Maloney","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib33","unstructured":"Food and Drug Administration: Accutane and Pregnancy Exposure, 9\/18\/2000.\u00a0Available: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/00\/slides\/3639s1c.pdf. Accessed March 2013."},{"key":"10.1016\/j.jpag.2013.05.007_bib34","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaad.2010.09.017","article-title":"The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system","volume":"65","author":"Shin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpag.2013.05.007_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/gut.2008.170530","article-title":"Isotretinoin and intestinal inflammation: what gastroenterologists need to know","volume":"58","author":"Shale","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jpag.2013.05.007_bib36","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108331881300185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108331881300185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:40:37Z","timestamp":1761054037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108331881300185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S108331881300185X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2013.05.007","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isotretinoin: Update on Controversial Issues","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2013.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013  Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}